glp 1 3rd generation What is the pipeline for future medications for obesity? Retatrutide is a “GLP-3” therapy,

CJC-1295 with DAC (Drug Affinity Complex) carries a maleimide linker that binds covalently to serum albumin, extending plasma half-life to approximately 68 days and producing a sustained GHRH-receptor signal

While it should never be viewed as a substitute for a nutrient-dense diet and a rigorous training program, it is an incredibly effective tool

Vyvanse is a prescription drug stimulant used to treat ADHD and moderate-to-severe binge eating disorder

NICE Key Therapeutic Topic KTT13 (Proton pump inhibitors) provides clear prescribing principles applicable to post-bariatric patients: use the lowest effective dose, review the need for continued treatment regularly (typically within 48 weeks of initiation or change), and implement a step-down or tapering plan when clinically appropriate